Arcturus Therapeutics Holdings earnings were -$68.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ARCT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$14.1M, down 53.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARCT reported annual earnings of -$80.9M, with 172.3% growth. The next ARCT earnings date is Aug 4, 2025.
Arcturus Therapeutics Holdings Earnings Reports & History FAQ
What were Arcturus Therapeutics Holdings's earnings last quarter?
On ARCT's earnings call on Invalid Date, Arcturus Therapeutics Holdings (NASDAQ: ARCT) reported Q1 2025 earnings per share (EPS) of -$0.52, up 48% year over year. Total ARCT earnings for the quarter were -$14.08 million. In the same quarter last year, Arcturus Therapeutics Holdings's earnings per share (EPS) was -$1.00.
When does Arcturus Therapeutics Holdings report earnings?
The next ARCT earnings date is Invalid Date. Add ARCT to your watchlist to be reminded of Arcturus Therapeutics Holdings's next earnings date.
What was ARCT's earnings growth in the past year?
As of Arcturus Therapeutics Holdings's earnings date in Invalid Date, Arcturus Therapeutics Holdings's earnings has grown year over year. ARCT earnings in the past year totalled -$68.20 million.
Is Arcturus Therapeutics Holdings profitable or losing money?
As of the last Arcturus Therapeutics Holdings earnings report, Arcturus Therapeutics Holdings is currently losing money. Arcturus Therapeutics Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$68.20 million, a 36.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.